The first Teva- Pharmaceutical Industries Ltd. trade was made in Q3 2011. Since then David Abrams bought shares four more times and sold shares on ten occasions. The investor completely sold their stake between Q3 2022 and Q1 2024.
David Abrams'' 13F portfolio value rises to $3.22B, while Meta Platforms and Teva Pharmaceutical witness stake reductions. Explore more here.